Safety and Effectiveness of Ocrelizumab under Real World Conditions: a Non-Interventional Post Authorization Safety Study in Patients Diagnosed with Relapsing or Primary Progressive Multiple Sclerosis (CONFIDENCE)

First published 06/03/2018

Last updated 10/09/2024

EU PAS number:

EUPAS22951

Study

Ongoing

Documents

Study protocol

Initial protocol

ML39632_NI-PASS Confidence fv1.0_2018-01-26_Redacted

English (1.02 MB - PDF) View document

Updated protocol

ML39632_CONFIDENCE_Protocol_V6.0_Redacted.pdf

First published: 10/09/2024

English (2.37 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs